|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/30 | |
| C07K 16/40 | |||
| A61K 39/00 |
| (11) | Patento numeris | 3134439 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15720854.7 |
| Europos patento paraiškos padavimo data | 2015-04-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/026806 |
| Data | 2015-04-21 |
| (87) | Numeris | WO 2015/164330 |
| Data | 2015-10-29 |
| (30) | Numeris | Data | Šalis |
| 201461982098 P | 2014-04-21 | US | |
| 201462004496 P | 2014-05-29 | US |
| (72) |
BRAKE, Rachael L., US
BURKHARDT, Anne L., US
HE MCDOUGALL, Helen D., US
KANNAN, Karuppiah, US
THEISEN, Matthew, US
TIRRELL, Stephen M., US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY |
| ANTI-PSYK ANTIBODY MOLECULES AND USE OF SAME FOR SYK-TARGETED THERAPY |